Personalized therapy offers new possibilities for targeted treatment and improved prognosis for patients with oncological and genetic diseases. The epicGEN technology enables precise and efficient analysis of gene mutation status, which is crucial for accurate therapy indication and disease progression assessment.
BioVendor provides user-friendly epicGEN NGS panels, which excel in maximum accuracy and high sensitivity. Thanks to optimized probes, they ensure uniform coverage of target regions, allowing reliable detection of genetic variants.
The epicGEN technology is designed for fast and easy implementation—it is fully compatible with common sequencing platforms and does not require any special equipment. With ready-to-use reagents, an intuitive workflow, and a comprehensive bioinformatics solution, it offers new opportunities for modern diagnostics.